|
Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe |
journalArticle |
2015 |
Bölling, T.; Braun-Munzinger, G.; Burdach, S.; Calaminus, G.; Craft, A.; Delattre, O.; Deley, M. C.; Dirksen, U.; Dockhorn-Dworniczak, B.; Dunst, J.; Engel, S.; Faldum, A.; Fröhlich, B.; Gadner, H.; Göbel, U.; Gosheger, G.; Hardes, J.; Hawkins, D. S.; Hjorth, L.; Hoffmann, C.; Kovar, H.; Kruseova, J.; Ladenstein, R.; Leuschner, I.; Lewis, I. J.; Oberlin, O.; Paulussen, M.; Potratz, J.; Ranft, A.; Rössig, C.; Rübe, C.; Sauer, R.; Schober, O.; Schuck, A.; Timmermann, B.; Tirode, F.; van den Berg, H.; van Valen, F.; Vieth, V.; Willich, N.; Winkelmann, W.; Whelan, J.; Womer, R. B. |
|
High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer |
journalArticle |
2015 |
Pailler, E.; Auger, N.; Lindsay, C. R.; Vielh, P.; Islas-Morris-Hernandez, A.; Borget, I.; Ngo-Camus, M.; Planchard, D.; Soria, J. C.; Besse, B.; Farace, F. |
|
Developmental predictors of inattention-hyperactivity from pregnancy to early childhood |
journalArticle |
2015 |
Foulon, S.; Pingault, J. B.; Larroque, B.; Melchior, M.; Falissard, B.; Cote, S. M. |
|
A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty |
journalArticle |
2015 |
Martelli, N.; Devaux, C.; van den Brink, H.; Pineau, J.; Prognon, P.; Borget, I. |
|
Precision medicine: lessons learned from the SHIVA trial - Authors' reply |
journalArticle |
2015 |
Le Tourneau, C.; Belin, L.; Paoletti, X.; Bieche, I.; Kamal, M. |
|
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia |
journalArticle |
2015 |
Selimoglu-Buet, D.; Wagner-Ballon, O.; Saada, V.; Bardet, V.; Itzykson, R.; Bencheikh, L.; Morabito, M.; Met, E.; Debord, C.; Benayoun, E.; Nloga, A. M.; Fenaux, P.; Braun, T.; Willekens, C.; Quesnel, B.; Ades, L.; Fontenay, M.; Rameau, P.; Droin, N.; Koscielny, S.; Solary, E.; Francophone Myelodysplasia, Group |
|
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status |
journalArticle |
2015 |
Messai, Y.; Gad, S.; Noman, M. Z.; Le Teuff, G.; Couve, S.; Janji, B.; Kammerer, S. F.; Rioux-Leclerc, N.; Hasmim, M.; Ferlicot, S.; Baud, V.; Mejean, A.; Mole, D. R.; Richard, S.; Eggermont, A. M.; Albiges, L.; Mami-Chouaib, F.; Escudier, B.; Chouaib, S. |
|
In reply to Alber and Sohn |
journalArticle |
2015 |
Benadjaoud, M. A.; de Vathaire, F.; Blanchard, P.; Cardot, H. |
|
Influence of the vocal cord mobility in salvage surgery after radiotherapy for early-stage squamous cell carcinoma of the glottic larynx |
journalArticle |
2015 |
Gorphe, P.; Blanchard, P.; Temam, S.; Janot, F. |
|
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis |
journalArticle |
2015 |
Blanchard, P.; Lee, A.; Marguet, S.; Leclercq, J.; Ng, W. T.; Ma, J.; Chan, A. T.; Huang, P. Y.; Benhamou, E.; Zhu, G.; Chua, D. T.; Chen, Y.; Mai, H. Q.; Kwong, D. L.; Cheah, S. L.; Moon, J.; Tung, Y.; Chi, K. H.; Fountzilas, G.; Zhang, L.; Hui, E. P.; Lu, T. X.; Bourhis, J.; Pignon, J. P.; Group, Mac-Npc Collaborative |
|
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives |
journalArticle |
2015 |
Mirghani, H.; Amen, F.; Blanchard, P.; Moreau, F.; Guigay, J.; Hartl, D. M.; Lacau St Guily, J. |
|
Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma |
journalArticle |
2015 |
Tejera-Vaquerizo, A.; Nagore, E.; Puig, S.; Robert, C.; Saiag, P.; Martin-Cuevas, P.; Gallego, E.; Herrera-Acosta, E.; Aguilera, J.; Malvehy, J.; Carrera, C.; Cavalcanti, A.; Rull, R.; Vilalta-Solsona, A.; Lannoy, E.; Boutros, C.; Benannoune, N.; Tomasic, G.; Aegerte, P.; Vidal-Sicart, S.; Palou, J.; Alos, L. L.; Requena, C.; Traves, V.; Pla, A.; Bolumar, I.; Soriano, V.; Guillen, C.; Herrera-Ceballos, E. |
|
Intramuscular administration of alfaxalone for sedation in rabbits |
journalArticle |
2015 |
Huynh, M.; Poumeyrol, S.; Pignon, C.; Le Teuff, G.; Zilberstein, L. |
|
Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: A study based on patient specific artery segments dose calculation |
journalArticle |
2015 |
Moignier, A.; Broggio, D.; Derreumaux, S.; Beaudre, A.; Girinsky, T.; Paul, J. F.; Drubay, D.; Lefkopoulos, D.; Franck, D.; Aubert, B.; Deutsch, E.; Bourhis, J. |
|
Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review |
journalArticle |
2015 |
Chouaïd, C.; Crequit, P.; Borget, I.; Vergnenegre, A. |
|
The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in France |
journalArticle |
2015 |
Scotte, F.; Martelli, N.; Vainchtock, A.; Borget, I. |
|
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials |
journalArticle |
2015 |
Paoletti, X.; Ezzalfani, M.; Le Tourneau, C. |
|
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study |
journalArticle |
2015 |
Jourdain, A.; Auperin, A.; Minard-Colin, V.; Aladjidi, N.; Zsiros, J.; Coze, C.; Gandemer, V.; Bertrand, Y.; Leverger, G.; Bergeron, C.; Michon, J.; Patte, C. |
|
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study) |
journalArticle |
2015 |
Raynaud, C.; Greillier, L.; Mazieres, J.; Monnet, I.; Mastroianni, B.; Robinet, G.; Fraboulet, G.; Dixmier, A.; Berard, H.; Lamy, R.; Letreut, J.; Lena, H.; Oliviero, G.; Botta, S.; Vergnenegre, A.; Borget, I.; Chouaid, C. |
|
Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years' experience in 87 patients from two centers |
journalArticle |
2015 |
Palussiere, J.; Lagarde, P.; Auperin, A.; Deschamps, F.; Chomy, F.; de Baere, T. |
|
Influence of the vocal cord mobility in salvage surgery after radiotherapy for early-stage squamous cell carcinoma of the glottic larynx |
journalArticle |
2015 |
Gorphe, P.; Blanchard, P.; Temam, S.; Janot, F. |
|
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial |
journalArticle |
2015 |
Le Tourneau, C.; Delord, J. P.; Goncalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Tredan, O.; Massiani, M. A.; Mauborgne, C.; Armanet, S.; Servant, N.; Bieche, I.; Bernard, V.; Gentien, D.; Jezequel, P.; Attignon, V.; Boyault, S.; Vincent-Salomon, A.; Servois, V.; Sablin, M. P.; Kamal, M.; Paoletti, X.; investigators, Shiva |
|
Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study |
journalArticle |
2015 |
Vale, C. L.; Rydzewska, L. H.; Rovers, M. M.; Emberson, J. R.; Gueyffier, F.; Stewart, L. A.; Cochrane, I. P. D. Meta-analysis Methods Group |
|
Nail toxicities induced by systemic anticancer treatments |
journalArticle |
2015 |
Robert, C.; Sibaud, V.; Mateus, C.; Verschoore, M.; Charles, C.; Lanoy, E.; Baran, R. |
|
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study) |
journalArticle |
2015 |
Raynaud, C.; Greillier, L.; Mazieres, J.; Monnet, I.; Mastroianni, B.; Robinet, G.; Fraboulet, G.; Dixmier, A.; Berard, H.; Lamy, R.; Letreut, J.; Lena, H.; Oliviero, G.; Botta, S.; Vergnenegre, A.; Borget, I.; Chouaid, C. |
|
Mortality from Circulatory System Diseases among French Uranium Miners: A Nested Case-Control Study |
journalArticle |
2015 |
Drubay, D.; Caer-Lorho, S.; Laroche, P.; Laurier, D.; Rage, E. |
|
Mortality from Circulatory System Diseases among French Uranium Miners: A Nested Case-Control Study |
journalArticle |
2015 |
Drubay, D.; Caer-Lorho, S.; Laroche, P.; Laurier, D.; Rage, E. |
|
The Use of Indirect Comparisons in Medicines Evaluation for their Access To Reimbursement by the Has |
journalArticle |
2015 |
Guichard, M.; D'Andon, A.; Rumeau Pichon, C.; Borget, I. |
|
Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases |
journalArticle |
2015 |
de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J. |
|
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study |
journalArticle |
2015 |
Libé, R.; Borget, I.; Ronchi, C. L.; Zaggia, B.; Kroiss, M.; Kerkhofs, T.; Bertherat, J.; Volante, M.; Quinkler, M.; Chabre, O.; Bala, M.; Tabarin, A.; Beuschlein, F.; Vezzosi, D.; Deutschbein, T.; Borson-Chazot, F.; Hermsen, I.; Stell, A.; Fottner, C.; Leboulleux, S.; Hahner, S.; Mannelli, M.; Berruti, A.; Haak, H.; Terzolo, M.; Fassnacht, M.; Baudin, E. |
|
Primary cutaneous and subcutaneous Ewing sarcoma |
journalArticle |
2015 |
Di Giannatale, A.; Frezza, A. M.; Le Deley, M. C.; Marec-Bérard, P.; Benson, C.; Blay, J. Y.; Bui, B.; Judson, I.; Oberlin, O.; Whelan, J.; Gaspar, N. |
|
How individual participant data meta-analyses have influenced trial design, conduct, and analysis |
journalArticle |
2015 |
Tierney, J. F.; Pignon, J. P.; Gueffyier, F.; Clarke, M.; Askie, L.; Vale, C. L.; Burdett, S.; Cochrane, I. P. D. Meta-analysis Methods Group |
|
Risk of Subsequent Leukemia After a Solid Tumor in Childhood: Impact of Bone Marrow Radiation Therapy and Chemotherapy |
journalArticle |
2015 |
Allodji, R. S.; Schwartz, B.; Veres, C.; Haddy, N.; Rubino, C.; Le Deley, M. C.; Labbé, M.; Diop, F.; Jackson, A.; Dayet, F.; Benabdennebi, A.; Llanas, D.; Vu Bezin, J.; Chavaudra, J.; Lefkopoulos, D.; Deutsch, E.; Oberlin, O.; de Vathaire, F.; Diallo, I. |
|
Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor |
journalArticle |
2015 |
Joskin, J.; de Baere, T.; Auperin, A.; Tselikas, L.; Guiu, B.; Farouil, G.; Boige, V.; Malka, D.; Leboulleux, S.; Ducreux, M.; Baudin, E.; Deschamps, F. |
|
Vandetanib for the treatment of advanced medullary thyroid cancer outside a clinical trial: results from a French cohort |
journalArticle |
2015 |
Chougnet, C. N.; Borget, I.; Leboulleux, S.; de la Fouchardiere, C.; Bonichon, F.; Criniere, L.; Niccoli, P.; Bardet, S.; Schneegans, O.; Zanetta, S.; Schvartz, C.; Drui, D.; Chauffert, B.; Rohmer, V.; Schlumberger, M. |
|
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials |
journalArticle |
2015 |
Dowsett, M.; Forbes, J. F.; Bradley, R.; Ingle, J.; Aihara, T.; Bliss, J.; Boccardo, F.; Coates, A.; Coombes, R. C.; Cuzick, J.; Dubsky, P.; Gnant, M.; Kaufmann, M.; Kilburn, L.; Perrone, F.; Rea, D.; Thürlimann, B.; van de Velde, C.; Pan, H.; Peto, R.; Davies, C.; Gray, R. |
|
Late toxicity of brachytherapy after female genital tract tumors treated during childhood: Prospective evaluation with a long-term follow-up |
journalArticle |
2015 |
Levy, A.; Martelli, H.; Fayech, C.; Minard-Colin, V.; Dumas, I.; Gensse, M. C.; Le Deley, M. C.; Oberlin, O.; Haie-Meder, C. |
|
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours |
journalArticle |
2015 |
Levy, C.; Allouache, D.; Lacroix, J.; Dugue, A. E.; Supiot, S.; Campone, M.; Mahe, M.; Kichou, S.; Leheurteur, M.; Hanzen, C.; Dieras, V.; Kirova, Y.; Campana, F.; Le Rhun, E.; Gras, L.; Bachelot, T.; Sunyach, M. P.; Hrab, I.; Geffrelot, J.; Gunzer, K.; Constans, J. M.; Grellard, J. M.; Clarisse, B.; Paoletti, X. |
|
Innovative medical devices and hospital decision making: a study comparing the views of hospital pharmacists and physicians |
journalArticle |
2015 |
Billaux, M.; Borget, I.; Prognon, P.; Pineau, J.; Martelli, N. |
|
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) |
journalArticle |
2015 |
Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P.; Asselain, B.; Azria, D.; Cardoso, F.; A'Hern, R.; Bliss, J.; Bogaerts, J.; Bonnefoi, H.; Brain, E.; Cardoso, M. J.; Chibaudel, B.; Coleman, R.; Cufer, T.; Dal Lago, L.; Dalenc, F.; De Azambuja, E.; Debled, M.; Delaloge, S.; Filleron, T.; Gligorov, J.; Gutowski, M.; Jacot, W.; Kirkove, C.; MacGrogan, G.; Michiels, S.; Negreiros, I.; Offersen, B. V.; Penault Llorca, F.; Pruneri, G.; Roche, H.; Russell, N. S.; Schmitt, F.; Servent, V.; Thürlimann, B.; Untch, M.; van der Hage, J. A.; van Tienhoven, G.; Wildiers, H.; Yarnold, J.; Bonnetain, F.; Mathoulin-Pélissier, S.; Bellera, C.; Dabakuyo-Yonli, T. S. |